已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Apoptosis-Related (Survivin, Bcl-2), Tumor Suppressor Gene (p53), Proliferation (Ki-67), and Non-Receptor Tyrosine Kinase (Src) Markers Expression and Correlation With Clinicopathologic Variables in 60 Thymic Neoplasms

生存素 胸腺癌 医学 酪氨酸激酶 病理 阶段(地层学) 胸腺瘤 精确检验 原癌基因酪氨酸蛋白激酶Src 免疫组织化学 肿瘤科 内科学 癌症研究 受体 生物 癌症 古生物学
作者
Thaer Khoury,Ainan Arshad,Paul N. Bogner,Nithya Ramnath,Shaozeng Zhang,Rameela Chandrasekhar,Gregory E. Wilding,Sadir Alrawi,Dongfeng Tan
出处
期刊:Chest [Elsevier BV]
卷期号:136 (1): 220-228 被引量:27
标识
DOI:10.1378/chest.08-2482
摘要

Our objective was to investigate the expression of survivin, Bcl-2, p53, Ki-67, and Src in thymic neoplasms and analyze their interrelationship with clinicopathologic variables.A series of 60 thymic neoplasms was reviewed and classified according to the World Health Organization (WHO) scheme. Key clinical information, including Masaoka stage, recurrence-free survival (RFS), and overall survival (OS) was obtained. The percentage and staining intensity of listed markers were recorded. The correlation of markers and clinicopathologic variables was statistically analyzed using the Fisher exact test and log-rank test.There were 7 type A, 15 type AB, 8 type B1, 5 type B2, 17 type B3 thymomas, and 8 thymic carcinomas. Seven patients (11.7%) died of the disease. Tumors recurred in eight patients (13.3%). Although p53 expression alone was found to be correlated with RFS with borderline significance (p = 0.056), patients with Src-positive and p53-positive coexpression had a shorter OS time than the other groups (p < 0.008). Cytoplasmic expression of survivin was present in 5 of 60 thymic neoplasms (8.3%), 4 of which were thymic carcinomas that all recurred.Regardless of WHO type and/or tumor stage, although p53 expression may predict recurrence in thymomas, p53 and Src coexpression can predict shorter OS, and cytoplasmic localization of survivin may predict recurrence in thymic carcinoma. These findings make thymic tumors a prime target for newly developed anti-Src and anti-survivin therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
快乐茗发布了新的文献求助10
刚刚
刚刚
打打应助科研通管家采纳,获得10
刚刚
英俊的铭应助科研通管家采纳,获得10
刚刚
小马甲应助科研通管家采纳,获得10
刚刚
李健应助科研通管家采纳,获得10
刚刚
地表飞猪应助科研通管家采纳,获得20
刚刚
香蕉觅云应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
1秒前
爆米花应助科研通管家采纳,获得10
1秒前
顾矜应助意昂采纳,获得10
2秒前
deng发布了新的文献求助10
2秒前
小昏发布了新的文献求助10
5秒前
7秒前
9秒前
12秒前
鼠鼠完成签到 ,获得积分10
12秒前
12秒前
13秒前
俭朴的元绿完成签到 ,获得积分10
16秒前
意昂发布了新的文献求助10
18秒前
丰那个丰关注了科研通微信公众号
19秒前
pluto应助快乐茗采纳,获得20
20秒前
风清扬应助大胆的时光采纳,获得10
21秒前
25秒前
传统的雨文完成签到,获得积分10
26秒前
小遇完成签到 ,获得积分10
26秒前
26秒前
JamesPei应助小昏采纳,获得10
26秒前
十分喜欢发布了新的文献求助10
26秒前
Lucille完成签到,获得积分10
27秒前
Aman发布了新的文献求助10
28秒前
英俊的铭应助哈哈哈哈采纳,获得10
31秒前
齐羽发布了新的文献求助10
31秒前
八二力完成签到 ,获得积分10
32秒前
Sheepycat完成签到 ,获得积分10
32秒前
33秒前
33秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976531
求助须知:如何正确求助?哪些是违规求助? 3520576
关于积分的说明 11204042
捐赠科研通 3257210
什么是DOI,文献DOI怎么找? 1798648
邀请新用户注册赠送积分活动 877835
科研通“疑难数据库(出版商)”最低求助积分说明 806555